Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures-Reference-Cited by-同舟云学术

Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures

Published:2021-11-24 Issue:12 Volume:96 Page:1679-1705
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Hallek Michael¹,Al‐Sawaf Othman¹

Affiliation:

1. Department I of Internal Medicine, University of Cologne, Center for Integrated Oncology Aachen Bonn Köln Düsseldorf, Center of Excellence on “Cellular Stress Responses in Aging‐Associated Diseases” University of Cologne Köln Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26367

Reference248 articles.

1. The Surveillance E and End Results (SEER) Program of the National Cancer Institute. Cancer Stat Facts: Leukemia—Chronic Lymphocytic Leukemia (CLL).https://seer.cancer.gov/statfacts/html/clyl.html;2021.

2. Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project

3. Incidence survey of leukemia in China;Yang C;Chin Med Sci J,1991

4. Subtype-specific incidence rates of lymphoid malignancies in Hong Kong compared to the United States, 2001⿿2010

5. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

Cited by 201 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic application of aptamers against leukemia, multiple myeloma and lymphoma: A review;Journal of Drug Delivery Science and Technology;2024-10

2. Chronic lymphocytic leukemia with MDM2 amplification as an alternative pathway to TP53 dysfunction;Leukemia & Lymphoma;2024-09-04

3. Eosinophilia During Lenalidomide Therapy in Myelodysplastic Syndrome;Clinical Lymphoma Myeloma and Leukemia;2024-09

4. Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors;Critical Reviews in Oncology/Hematology;2024-09

5. Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice;Oncohematology;2024-09-01